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I. INTRODUCTION 
Acute hemorrhagic pancreatitis (abbreviated to acute pancreatitiヘ hereafter) 1s one 
of the characteristic diseases as featured by its fulminant clinical picture and unfavorable 
prognosis. As a cause of this fact, intoxication due to liberation of pancre司tic enzymes 
has been emphasized. Among these emym引， amyl川 eis proved to increase in blood cor-
respond inεto the development of the disease. However, ;1ベto lipase and trypsin, parti-
cularly the latter, conspicuous increase is not demonstrated partly clue to the difficulty of 
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determination until recent years. 
On the other hand, it has attracted interest of many investigators since HILDEBRANDT・5
report in 1893 that there exists antitrvptic activity in serum. Moreover, in 1948 KuNITZ28> 
extracted some substance from the pancreas which inhibits the activity of trypsin and clar-
ified it'> plwsical and chemical characters, which was then followed by successive discoveries 
of theミubstanceshaving the same action within animal’s tissue, plants of some kinds and 
more primitive animals and character只 ofthese substances have gradually been disclosed 
up to present4BJ1BJI9)1aJ16)6)7J川 35>53J HJ. Today, these substances are commonly called 
try psi 1i 1hihitor or antitrypsi 1'5l 3oi. Essential and character of each of these substances, 
however, are much different from each other, and details in this respect are not yet 
clarified. 
Pancreatic trypsin inhibitor (abbreviated to P T. I., hereafter) as reported by KuNITZ 
normally exists in pancreatic juice and inhibits simultaneously elaborated trypsinogen to he 
activated to trypsin within the pancreatic parenchyma or pancreatic duct, or it has an effect 
to combine itself with once activated trypsin to inactivate it57l. As pancreatic juice appears 
in the duodenum, prokinase coexisting in the pancreatic juice is activated to enterokinase, 
which comes to surpass inhibitory action of P. T. I. and produces active trypsin. Protein 
dig＜：吋inεactionof trypsin finally works here59> 26l. At acute pancreatitis, however, the 
process is somewhat different, considerable amount of active trypsin being found within 
the pancreas, and it is considered that as it is liberated from the pancreas51l, P. T. I. also 
comes to appear in blood stream, surrounding tissue and peritoneal cavity. 
Character, mode of reaction and behavior at the diseased state of antitryptic properties 
in町 rumhave been widely investigated by many researchers. As to the location of this 
property, LλNDSTEII叩 R maintained in 1900 its existence in albumin fraction by means of 
~alt fractionation, which was thereafter followed by many approvals. In 1953, however, 
I》E¥N.¥SKY and L主SKり＼＼＇SKI1l isolated tn・i】叫ninhibitor from a 1 globlin fraction. In 19:15, 
SHUU.IAN46l further isolated another tr:<psin inhibitor from f¥'2-globlin fraction. These results 
were ascertained by means of electrophoresis by ]ACOBSSON24l in the same year. Recently, 
!Jyn: and HA VER BACK"> also reported the same results. GROB"> has identified the 
lりcationof trypsin inhibitor usin広COHN、Rfractionation method. 
In addition to these, KAZAL et al2n. have demonstrated the existence of another in-
hibitor, so-called KAZAL °＇ミ inhibitoror second inhibitor, whiι・h is different from that di日cover-
ed by KuNITZ. Mor駒沢~r, there are reports of discovery of inhibitor in urine15l or colos-
trum32>, hut it is not clarified whether or not this inhibitor is identical to above described 
、cruminhibitor. 
.＼メ acause of the phenomenon that increa蛇 in対 rumtrypsin is not so prominent at 
acute pancreatitis, mechanism of trypsin inactivation by these trypsin inhibitors can be 
inferred. Following experiments were attempted in order to ascertain this possibility, and 
in order to clarify complicated pathophysiologv which may justifiably he called self-defence 
reaction and further to disc、losL'the significance叶 this process in acute pancreatitis by 
clari fyin只 activity relationship between trypsin inhibitor and liberated trypsin from the 
pancreas. 
It i" accepted generally that trypsin and trvpsin inhibitor combine with each other 
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forming inactivated compound, which is enzymodynamically represented as follows ; 
T+Iι二三T・I. whereby T represents trypsin, I trypsin inhibitor and 
T • I trypsin-trypsin inhibitor compound. 
It is also said that in this formula the velocity of the reaction is maintained constant depend-
ing upon the conditions of the reaction, consequently above mentioned three components 
being held in equilibrium23><oJ. At acute pancreatitis also liberated trvpsin and trypsin 
inhibitor are considered to form coexistence of three components of active trypsin, active 
trypsin inhibitor and inactivated compound in a certain proportion. Although active trvp,;i1 
and active trypsin inhibitor can be determined, amount of trypsin-trypsin inhibitor compound 
and amount or activity of each of trypsin and trypsin inhibitor which form the compound 
cannot be properly determined at present with some exception. On the other hand, in-
hibitory activity is presumed to be consisted of various trypsin inhibitors within the material, 
and there is no suitable method of respectin:' determination of these inhibitors. Hence. in
the present experiment, active trypsin, acti¥'t:' trvpsin inhibitor and P. T. I., which is the 
sum of inhibitor of active form and combined form, are rじーpじじtin~h- determined. 人tthis 
point, such reaction between trypsin and trypsin inhibitor gives an impre,;,;iり1that the reac-
tion well resembles antigen・antibodyreaction in immunology. Little is known, however, 
concerning the田sentialand mutual relationship of these reactions, today. Accordingly, in 
the present experiment study was not carried out in the immunological aspect. 
In the present paper, activity of inhibitor in materiab were represented in the term 
of antitryptic activity (abbreviated toえ T.A.). 
I. MATERIALS AND METHODS 
l. Animals: Adult mongrel dogs weighing approximately 10 kg were used. 
2. Production of Acute Pancreatitis The abdominal cavity was opened under mtra-
venous anesthesia of IsozoL. Bile was aspirated by gall bladder puncture with a small 
needle. The main pancreatic duct was exposed and isolated from the surrounding ti同 ue,;
near its duodenal opening and the bile of 0.3 ml per kg body weight was injected into 
the main pancreatic duct under large pressure. The main duct was ligated with silk-
thread, lest the injected bile should flow out into the intestine. Postoperatively, administra-
tion of antibiotics and fluid trans£ usion were withheld since a possibility of trypsin inhibit-
ing effect of antibiotics and that of influence of fluid transfusion upon the amount of 
peritoneal fluid were suspected. It was also ascertained that Isl＞χ（ >L has no interference 
on experimental result宍 bythe comparative determination performed beforヒ andafter the 
injection of this agent. 
3. Collection of Serum and Peritoneal Fluid Blood of several ml was taken from 
the fem oral vein certain period of time before and after the operation. Serum was separated 
immediately and subjected to the determination. Peritoneal fluid ¥'as collected through a 
small rubber tube inserted from an incision in the right hypochondrial region, one end 
being placed behind the duodenum slightly directed below. Another end of the tube was 
closed with a clamp, which wa" released when in u吋
4. Preparation of Ti,;sue Specimen・ Tissue o.ectin,; of about l日weretaken, when 
necessary, by cloulile ligation, laparotom：－’ being 仁川ried( 1utじげtaininterval of time after 
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the production of acute pancreatitis. 
5. Fal;;e Laparotomy : As in the production of acute pancreatitis, the abdomen was 
opened, and the operation was performed merely to the extent to aspirate bile and expose 
the main pancreatic duct. 
6. Determination of Trypsin Activity: Method of NARDI3n3s>39> was followed, which 
is summarized a~ follows. 
i. Material is heated at 65 C for 15 minutes. 
i. Buffer solution (phosphate buffer solution N/15, pH 7.8) of 0.5 ml and benzoyl 
1-arginine amide hydrochloride monohydrate (abbreviated to B. A. A., hereafter) substrate 
solution of 1.0 ml are added to 0.5 ml of the material. The mixture is incubated at 25°C 
for an hour being shaken. 
ii. On the other hand, 1.0 ml of boric acid solution and 2 drops of indicating reagent 
are put in the inner chamber of the CoNw；町、sunit, which is then tightly closed with a 
glass cover sealed with 川町line.
iv. An hour later, 0.2 ml of the mixture in above described i. is poured in the outer 
chamber of the CONWAY.只 unit.
v. Immediately, 1.0 ml of saturated K2C03 solution is pipetted in the opposite side of 
the outer chamber carefully so that the solution may not mix together with previously 
poured mixture of the material. 
vi. The chamber is tightly closed with a cover and rotated 15 times, which is then let 
alone for an hour. 
vi. An hour later, the material is titrated with hydrochloric acid of 0.01 N using micro-
biurette until the change in color of boric acid caused by transference of pH returns to 
that of blank material, and consumption of hydrochloric acid is read. 
vii. As the blank, 0.5 ml of buffer solution was used instead of the material with the 
identical procedures. 山 lutionof crvstalline trypsin (Tripure; Novo Industry) of previously 
known activity was determined by this method, and trypsin activity which required lpl of 
hydrochloric acid at titration was calculated and average value of 0.705×10 4 ANSON units 
was obtained. Acti,・ity of trypsin was represented in the term of ANSON unit (abbreviated 
to A. U., hereafter) which was conwrted from the amount of hydrochloric acid consumed 
at titration. As there exists ammonia of free type in peritoneal fluid, the value obtained 
from the determination with the material added with buffer alone insted of B. A. A. was 
substracted from the actually determined value. 
7. Determination of P. T. I. : P T. I. was extracted following the method of KALSER-
G応対日丸山26>,and subjected to the determination of hemoglobin method of ANSON1> 2>. 
Results were represented in the term of A. U. !ml. Procedures of the determination are 
summarized as follows. 
a) Extraction 
i .，、richloracetic acid of 5 per cent solution of 2.0 ml is added to the same amount 
of tested mall'rial. 
i. The mixture is heated in a water bath of 80° C for 5 minutes. 
I i. It 刊 thenl'l'ntrifugecl fけr5 minutes at 2000 r. p. m. and filtrated. 
i,・. The自upernatantis extracted with ether of the samじ amountfor two times and 
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remaining ether is evaporated under partial vacuum. 
v. The material is adjusted to pH 7.0 with 0.05 N NaOH using B. T. B. as indicat-
ing reagent. 
b) Binding 
Thus adjusted material of 0.5 ml is mixed together with 0.5 ml of diluted tryp-.,11 
solution and kept at 5 （＿、 for30 minutes. 
c) Digestion 
i. Thirty minutes later, 5.0 ml of hemoglobin substrate solution is added to the material 
and well stirred, which is incubated at 25' C for 10 minutes. 
i. Accurately 10 minutes later, 10 ml of 0.3 N trichlor acetic acid is added to the 
material and adequately mixed to interrupt digestive process and, at the same time, let 
stand for 30 minutes to precipitate surplus protein. 
ii. The precipitate is filtrated through a hard filter paper (Toyo-roshi, No. 131). 
d) Development of Color 
i. Ten ml of 0.5 N NaOH is added to 5.0 ml of the filtrate and 3.0 ml of diluted 
phenol reagent is gently dropped to develop the color, the filtrate being shaken. 
i. Approximately 10 minutes later, the material with completely developed color of 
blue is subjected to spectrophotometry through a filter of 660 m11. 
e) Blank Determination for AnsorピsMethod 
Procedures are entirely identical until above mentioned process of b). Here trichlor 
acetic acid of 0.3 N is added to substrate solution. After well stirred, the mixture of b) 
is added and filtrated 30 minutes later. One ml of tyrosine solution prepared with hydro-
chloric acid of 0.1 N, which contains formalin as preservative in a proportion of 0.5 per 
cent, to be 0.0008 mEq ml is added and the color is developed as in the above. 
f) Activityァ ofControl Trypsin Solution 
In this determination, the material was replaced with distilled water, and the proce司
dures otherwise were completely similar to the actual determination. 
g) Standard Tyrosine Solution 
Tyrosine is dissolved in 0.2 N hydrochloric acid, containing formalin for preservative 
in concentration of 0.5 per cent, to be 0.0008 mEq/5ml, which is similarly developed to 
produce adequate color. 
h) Calculations 
1. Tyrosine in dig田凶山ピ叫） = ~× 8 × 10 4 
, S 1 19 I 
1. Tyrosine in the blank (mEq) = （×8×10 ×）－8×10-4 
¥ B lS ' 
u1. Correction of the blank value二 i. i. 
S =Transparency of standard tyrosine solution 
Dニ Transparencyof digested filtrate 
B二 Transparencyof the blank in e). 
1v. In occasion of control trypsin 片付lution,the c1lculations are entirely ~imilar. 
v. The value of tyrosine obtained from ii. and i＼＇.けれ白 じけ1＼＇じrtedto tn·p~in J川 i¥'it¥' 
using previously drawn standardじun・じ・
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v1. Trypsin activity of material filtrate is substracted from that of the control. 
vi. Activity of trypsin inhibitor in the material of 1 ml is obtained from the value宮
obtained from above mentioned calculations. 
8. Determination of A. T. A.: GROB0s method19> was employed in A. T. A. determina-
tion, and trypsin activity was determined using hemoglobin substrate following ANSON’s 
method1>2>. Results were represented in the term of A. U.;ml. Essentials of the determina句
tion are summarized as follows. 
i. The material is diluted 100 times with pH 7.6 phosphate buffer solution of N/10. 
i. Previously prepared and preserved trypsin solution is similarly diluted 50 times with 
the buffer solution. 
ii. Diluted trypsin solution of 0.5 ml is added to 0.5 ml of diluted solution of the material, 
which is kept 15° C for 20 minutes. 
iv. Trypsin activity is determined hy Anson、smethod 20 minutes later. 
v. As the blank determination, procedures are completely identical using buffer solution 
instead of diluted trypsin solution. By this determination, proteolytic activity in the material 
can be known, which is, however, as small a value practically, as well be neglected. 
vi. Blank determination is performed in the same manner as in the determination of 
P. T. I. 
vi. For the control, the determination is similarly carried out using the same amount 
of buffer solution instead of diluted material. 
vii. Calculations are similar to those in P. T. I. determination. Here the proteolytic 
activity in the material should be substracted from the results as blank according to the 
following formulas. 
〔Valueof iv-Value of vi〕〔Valueof v Value of vi〕－－－－－－－－－－－一（ 1 ) 
Value of vi Value of vi ・ －－－ーー・ーー・・ー・・・・・・・・・・・・・・・・・・・（ 2) 
Data of (1) and (2) are converted to trypsin activity by the use of the standard 
curve. From the difference of these two, antitryptic activity per ml of the original material 
can be sought. 
9. Determination of A. T. A. in Tissues The determination was done being based 
on the method of tissue antiplasmin determination of MACFARLANE and BIGGs34人
i. Approximately 1 g of piece of tissue taken is adequately rinsed with saline solution 
to remove blood. 
i. Piece of the tissue is dried being held between 2 sheets of filter paper. 
ii. It is then weighed accurately to the extent of 10 mg. 
iv. Appropriate amount of saline solution, generally 5 to 6 volumes, is added to the 
piece of the tissue, which is homogenized being cooled with water. Homogenous suspen-
sion thus obtained is centrifuged. 
v. The supernatant is diluted with N/10 phosphate buffer solution of pH 7.6 finally 
to becomt・‘100 tinwべdilution,includinεthe dilution with saline 
vi. Activity of trypsin inhibitつTof the diluted mate‘rial is determined following the method 
of (;!WR. 
vi. Antitryptic activity per 1氏。fti帆 Lil'thus obtained is reprL『じntcdin the term of人．
lT 
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10. Crystalline Trypsin：“ Tripure '(Novり Industry) wa~ used for the 仁ontrolof 
trypsin inhibitor determination. Each vial contains 50 mg of crvstalline trypsin (1.25λ 
U.) with calcium salt as stabilizer20人 Crystalline trypsin is solved in 0.0025 N hydro-
chloric acid in a concentration of 1 mg/ml finally being pH 3.0, which is pre町 n・αlin 
refrigerator and newly prepared むverv two weeks. The trypsin solution is diluted as 
described in the above with the buffer solution to be pH 7.59 which is most suited for 
trypsin to act. 
11. B. A. A. Substrate Solution B. A.λ （Daiichi Chem. lndust.) was dissolved in 
N/15 phosphate buffer solution 0f pH 7.8 to a concentration of 0.1 M. 
12. Indicative Reagent : In the determination following the method of NARDI, solu-
tion of 5 volumes of 0.1 per cent absolute alcohol solution of brom cresol green 
and 1 volume of 0.1 per cent absolute alcohol solution of methyl red was used. For ad-
justing pH in the method of K.孔LSER-GROSSMAN,solution of brom thymol blue was used. 
13. Hemoglobin Substrate2l Eight ml of 1 ~ ：山OH,36 g of urea, 10 ml of 22 per 
cent hemoglobin solution (Merck) and 72 ml of distilled water are mixed together and 
incubated at 25"C for 30 to 60 minutes to debase hemoglobin. After incubation, 10.0 ml 
of 1 M KH2POぃ 4g of urea and approximately 2 g of Mersonin, as preservative are added 
finally to become 100 ml in al. The substrate solution is preserved in refrigerator and 
newly prepared every 2 weeks. 
14. Microbiurette Microbiurette (Shibata Chem. Co.) of precision type having total 
capacity of 0.1 ml with graduation of 1 microliter. 
15. Phenol Reagent: Phenol reagent (Daiichi l、hem.lndust.) following the recipじ of
FuuN-C、IOULTEAU was used being diluted 3 times with distilled water. 
16. Spectrophotometer Spectrophotometer Junior Model 6 A, N0.え 41453(Cole-
man Cu.) was used. 
17. Measurement of Blood Pressure A cannula was inserted into the femoral artery, 
which was connected to a mercurial manometer. As an anticoagulant, oxalate was used 
instead of commonly used heparin that has antitryptic property22l. 
18. Standard Curve ・ In the process of spectrophotometry in ANso:--: s method, a 
standard curve should be drawn which shows the relationship between tranparency i. e. 
concentration of tyrosine and unit of trypsin activity. Amount of newly produced tyrosine 
at various concentrations of crystalline trypsin is plotted on a graph with tyrosine concentra-
tion (mEq) in vertical axis and trypsin activity (A. U.) in horizontal axis. Thus obtained 
curve is used as the standard. 
III RESULTS 
1. Changes in Active Trypsin and Trypsin Inhibitor caused bv Laparotomy alone 
In order to clarify the influence of laparotomy alone on the determination, trypsm 
activity, P T. I. and A. T. A. in blood were determined before and aiter falsl' lap:1ro・
tomy. Results obtained are shown in Fig. 1. It lメ consideredto be quite natural that 
there should be no significant chan除、 intrypsin activitv and P. T. I，メincethe proL・edure 
of the false laparotomy does not hurt the parnγ山只 itself. I-fowe¥・er, in the ch江n昨 in.¥. 
T. !¥., two peaks were observed 6 hours and 7-:_ hours postけperati＼アelvthe latじrbein只
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Fig. 1 Active trypsin S: inhibitor m田rumat exploratory laparntけIll¥
persistent until 7 days after the operation. 
Determinations of these properties were performed in dogs of acute pancreatitis. There 
was much difference in trypsin activity or activity of trypsin inhibitor between cases of 
early death with serious symptoms and those of long survival or complete recovery, even 
though acute pancreatitis was produced in the same manner. Accordingly, the animals 
were classified into 2 groups of early death within 48 hours and long survival. 
2. Changes in Serum Trypsin and Trypsin Inhibitor at Acute Pancreatitis 
Active trypsin, P. T. I. and A. T. A. in serum in dogs of acute pancreatitis are shown 
in Tab. l to 3, and the average values of these are summarized in Fig. 2. 
a. Active Trypsin; Active trypsin can be found even in normal cases, but it showed, 
after onset of the disease, rapid then mild increase reaching its peak of 2町89×104 A. U. 
in cases of early death, and 2.68×10-4 A. U. in四sesof long survival, on the average, 
24 hour later, which was followed gradual decrease to restore to normal level or more 
low level towards 7th day of the disease, sometimes reaching zero. 
b. P. T. I. ; In normal cases, it ranged around 1.7×10-4 A. U. on the average. In 
cases of early death, it decr回 sed slightly until 24th hour and in those of long survival 
slight fluctuation could be observed. In the later, P. T. I. showed delayed increase com-
pared with that in active trypsin, reaching its maximum value of 4.79×10-4, on the average, 
5 days after the onset of the disease, which is followed by gradual decr回 sethereafter to 
final level of normal, 14 days after the onset of the disease. 
c. A. T. A. , Although individuality of A. T. A. in normal animals was larger than 
above mentioned two, the fluctuation showed similar tendency. Namely, it decreased marked-
ly in ι川引 ofearly death 6 hours after the onset of the diーとase,being followed by further 
decrease until 12th hour of the disease. Towards 24th hour of the disease, it showed an 
increase, hut it remained below preoperative level, with only one exception. Obvious and 
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Table 1 Active lrvpsin m serum unit: JQ-4 A. U./ml. 
Ca配 of回 rlyd白 th ca日 oflong出 rvival
Dog. No辰JトI6H 12H I加 JoogNo.IPreop.1 6H ［己i司24H
吋咋 1.06 I 2.82 I 3.17 ト 10♀ 0.11 2.12 I 2.s2 
メ－co 0.35 I UJ 1.76 ! 1.76 S-J 1♀ 0.71 L!l 2.82 
i¥-9♀ I 0.71 I J.76 ! 1.76 i 2.12 liA-16合 ：o.35I 1.4.1 : 1.76 
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2.12 ! 2.47 I liA-17♀ 1 .06 i 1.16 I 2.82 
2.82 ; 3.17 I A-19合：0.88 2.33 2.88 
1.16 2.12 ; 2.48 吋 1ー3♀ 0.71 2.12 2.47 
1.05 2.08 i メ lーl♀ 1.06 1.41 ! 2.12 
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2.82 : 2.82 I 2.47 
3.171 2.47 i 1.41 
3.53 3. J 7 I 1.76
ヨ.82 2.12 I !.06 
3.53 2.47 : 1.41 
2』7 2.82 I 1.41 
2.82 I 2.82 I 1.41 I 0.71 
2.68 I 2.55 I 1.54 I 1.06 
1.76 1.06 '0.71 
1.06 0.35 
1.06 0.71 
1.06 0.71 : 0.35i 0.35 
0.71 0.35 
0.71 
0.64 : 0.26; 0.21 
1.-1 2.82 S-17'0 
2.82 ! 3.5] 3.88 メー 180
メ 1ー9♀
2.06 2.61 ' 2.89 : ;vt，.，川
0.71 1.76 2.12 
1.41 I 1.15: 2.41 
0.71 I JI j 2.~ 7 
0.7 I 1.77 2.45 
Table 2 P. T. I. in 'erum unit : 10 4 .¥. U./ml田
山 叱 ofearly c!eath 山間 oflung >Ur¥'ival 







Dog No. IPreop. i_ 6H i 12Hド4H~Dog瓦 !Pr叫 I 6H J 12H I 2-1H I 48H I四 Iso / 71J lrnoj1rn 
s,.1♀ 2.31 1.75 1.60 ト 10♀ 1.98i 1.12 1.81 ! 2.20 I 2 . 19 3.02 I i.o4 I 
日 o 2.05 2.30 1.61 1.52 S -11♀ 1.90 i 2.29 i 1.85 ! 1.70 i 2.4 I ! 3.80 I 5.18 I 
ト 9♀ ，2.t7 I '.2.-10 1.76 j 1.76 川 崎 2.3sI - 2.13 I 2.s』 3.o9I 1.31 1 l i 
ト 3♀ 0.68i 1.82 I I is -Iコ♀ 1.78! 1.61 I 1.60 ! 1.83 I 2.69 I 3.33 ! 3.86 I 2.3212.10.1.82 
ト岬 ；1.56I 1.58 I 1.22 I 1.03 ト 15♀ 1.s2 i 1.49 1 1.55 I 1.65 I 2 81 3.66 : s.~2 .191 - u5 
品－5合 2.69! 2ぉ I1.08 I 0.76 . ¥-18♀ 1.58 1.69 . 1.81 I J .90 I 2.51 : 3.35 i 1.84 4.06 ー ；2.37
λ・7合 ：1.53I 1.39 I 1.25 I . .¥ -17♀ 2.2s I 1.40 I 2.08 I 2.41 I 2.37 I 3.59 
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Fig. 2 
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significant difference could be observed between case~ of long叩 rvi，.λl and l'arlv’death, in 
the former it decreasing rapidly at 6th hour and contrariwise increasing to exceed the 
preoperative level at 12th hour of the disease, in most cases. The increase stil continued 
on thereafter to 195.2 × 10-• . ¥.LI., 48 hours after the onset of the di~e<tse, on the average, 
which was followed by gradual decrease to restore to normal level towards 5th day of the 
disease, showing further decrease in most cases. 
3. Changes in Acti¥'e Trypsin and Trypsin Inhibitor in Peritoneal Fluid at入t・utゼ
Pancreatitis 
Relationship between active trypsin and trypsin inhibitor was studied with the mate-
rials of peritoneal fluid and serum simultaneously taken, data of which are shown in Tab. 
4 to 6, each average value in Fig. 3 to .l Aメ the amount of peritoneal fluid lessened 
over 72 hours after the onset of the disease practically, and it became hard to collect the 
fluid owing to progressive intraperitoneal adhesion or the fluid became supprative at this 
Do巨 「ぜり
主ー 1 C5 
.¥-2 ♀ 
主ー 3 C5 
主－ I C5 
礼－5 ♀
主－6 0 







Table 4 主l'i、t'tr、1≫i1in serum and perit ・ineal fluid 
S serum, . ¥ peritoneal fluid 
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Table 5 P. T.I. in serum and per山川町lfluid unit : 10--1主 U./ml
沿 serum, .-¥ peritoneal fluid 
uppぞr: ca'e of白rlydeath lower : ca担 oflong 、mvival
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2.11 i 3.35 2.57 
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2.13 3.89 2.16 
1.88 ! 3.75 2.33 
l.66 3.26 1.34 
1.8-1 2.24 2.62 
1.89 ' 3.56 1.98 
stage, making the data incredible, collection of peritoneal fluid was carried out until 72nd 
hour of the disease even in cases of survival. 
a. Activt'‘Trypsin ; In both groups of early death and long survival, active trypsin 
of peritoneal fluid slightly exceeded that of serum. The difference gradually became smaller, 
becoming obscure in general 24 to 48 hours after the onset of the disease. Active trypsin 
of peritoneal fluid, however, exceeded, though slightly, that of serum 72 hours after the 
onset of the disease. 
b. P. T. I・iP T. I. in peritoneal fluid was generally les than in serum 6 hours 
after the onset of the disease, which increased onεradually in both groups of early death 
and long survival in most cases, exceeding the level in serum 24 hours after the onset of 
the disease. It is noticeable that P. T. I. level of peritoneal fluid was persistent to the level 
of about 2×10 4 A. U., while P. T. I. of serum increase<l thereafter. 
c. A. T. A. ; A. T. A. of peritoneal fluid and serum showed resembling curves to 
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Table 6 .-¥. T. 礼川 serum 川id問ritonealfluid 
6 H 12 H 21 H 
Dog Nn. """ >p 
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each other, the former never exceeding the latter and being kept approximately on the 
｜じwlof 75 per cent of the former. The difference between cases of early death and 
those of long survival was also most prominent in :¥. T. A. as in同rum.
4. Changes in Active Trypsin, Trypsin Inhibitor and Blood Pressure at Intravenous 
Injection of Cn·~talline Trypsin in Dogs sunived AじutePancreatitis 
In order to study the response a伊 instinjection of trypsin of considerably large amount 
in do昨日un・ivedacute pancreatitis (abbreviated to“知r、in:・ddog ”，hereafter), fluctuation 
of blood pressure, acti＼・ゼ 1r ~· psin in blood and inhibitor expressed as A. T. A., in the sur-
vived dogs in which trypsin solution was injected from the femoral vein spending 10 minutes, 
were pursued. Trypsin solution was prepared in 25 ml of saline in a proportion of 4 mg 
per kg bαly weight. Results obtained are summarized in Fig. 6 and 7. 
a. Active Trypsin; Although it is quite natural that active trypsin should show the 
maximum of 5.56 × 10-• A. U. immediately aftぞrthe injection in normal animals, it was 
followed by relatively rapid decre;1sぞ until60 minutes after the injection reaching a half 
level compared with the maximum. However, decrease thereafter was mild, showing a 
level as 1.45×10→ λ.u.引 eぞn150 minutes after the injection. On the other hand, the 
maximum of sun・ived dogs was a litle lower than in normal ones, being 5.1 × 10-• A. U., 
which was followed hv a certain decrement thereafter, restoring to normal as early as 
100 minutes after the injection, and trypsin acti¥・it¥' could not be observed 120 minutes 
after it. 
h. A. T. :¥. , In normal dogs, .-¥. T. A. slightly increased as shown in the figure, 
with following decrease, while in suτVl¥・ed do伊 itdecre郎氏lfrom the beginning. A.T.A. 
in both animals decreased revealing similar level thereafter until 60 minutes after the in” 
jection. Later than 60 minutes, A. T. A. in survived clogs showed a tendency of gradual 
increase with slight fluctuation, wherea六 innormal dogs it continued to decrease on finally 
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Fig. 6 Inhibitor ＆‘:lcll¥＂（色付、 p>inafter int川、c101>injection of crystaline tn・p,11 
to reach as low a level as 20×10－・入 U.100 minutes aiter the injection and it tended 
to restore as late as , 120 minutes later. 
c. Blood Pressure , Animals of both experiment and control showed the symptoms of 
shock with marked descension of blood pressure 5 minut巴safter the injection, when the 
injection was not finished yet. Survived do停， however,soon recovered showing blood 
pressure of about 70 mmHg, 20 to 100 minutes after the injection, and further, showinε 
the restoration to normal level later than 130 minutes, while in normal do同 bloodpressure 
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remained within the range of 40 to 50 mmHg until 150 minutes after the injection, show-
ing no sign of rと仁川ピrv.
In this experiment, 25 ml of saline was injected in the similar way for the control. 
In these animals, hlood pressure and A. T. A. were examined with the outcome of tern-
poran・ and slight fluctuation of hlood pressure alone. 
5. Changes in Antitryptic Activitv in Various Organs at Acute Pancreatitis and after 
Intravenous Injection of Crystalline Trypsin 
As in the previous experiment, trypsin was injected intravenously and specimens were 
taken from the liver and spleen hefore and after the injection, and A. T. A in the homo-
広enateof these pieces of the organs was determinιd. Results obtained are shown in Fig. 
8 together with active trypsin and A. T. A. in blood simultaneously determined. Organ 
specimens were taken only 3 times, i. e. before the injection, 60 minutes and 120 minutes 
after the injection, which was so confined being related to the time of biopsy. A. T. A. 
in the li¥・er of normal dogs decreased and that in the spleen showed hardly discernible 
change, whereas in survived animals A. T. A. in both of the liver and spleen increased, 
though sliεhtly, with obvious difference from those of normal animals. Here, trypsin in-
hihitor of the liver and spleen were determined as well as A. T. A. in blood in experi-
mentally produced acute pancreatitis. The results are shown in Tab. 7 and the average 
valuccs are summarized in Fig. 9. Compared with activity of trypsin inhibitor in 1 ml of 
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serum, that of trypsin in hi bit or per 1 g of ti州 Lit、couldbe said to be low. >iL・1げ theIt引，
what was so interestin只wasthat changes in tissue A～T. A and serum A. T. .'¥. was in-
versely proportionate to each other until 24 hours after the cm.;et of the di宍ease,and par-
ticularly that A. T. :.¥ in the li¥'t:'r increased rapidly and temporarily showing steep peak 
of as high a level as twice of the preoperative level 6th hour of the disease, as if respond-
－：’、
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ing to temporary rapid decrease in A. T. A. in serum. Thus, A. T. A. in the tissues 
continued to increase gradually later than 24 hours after the onset of the diseas巴 regard-
les of the change in serum A. T. A., A. T. A. of the liver constantly showing higher 
level than that of the spleen. In general, changes in A、T.入、 ofthe liver was more 
marked than that in A. T. A. of the spleen. 
IV. DISCUSSION 
There have been many reports on the method of producing experimental acユtepan-
creatitis, such as ligation of the pancreatic duct, ligation of the pancreatic vessels injection 
of olive-oil, bile of pig, trypsin or intestinal content into the pancreatic duct and combina-
tions of these. Among these, injection of autogenous bile is the most simple and suited 
to the aim of producing clinical pictures as typical edemヨ， hemorrh叫eor necrosis Amount 
of bile for the injection was decided to be 0 3 ml per kg body weight, sinc七 too much 
serious pancreatitis was produced to pursue the relationship between trypsin and trypsin 
inhibitor, which was the original aim of the present experiment, when the bile of more 
than 0.4 ml per body weight was injected, and, on the contrary, when the bile was les 
than 0.2 ml per kg body weight, the injection resulted merely in the slightest edema, 
without producing pancreatitis of appropriate degree. Concerning the pressure for the in-
jection, condition was maintained invariably by using the same syringe and needle (gauge 
22) and injecting the bile spending 1 second for 0.5 ml, since too slow injection produced 
too slight picture of the disease. Success of the injection could be discerned from the 
change in the color of the pancreas into yellow-brown, sεveral minutes afterwards. 
There are many devices for the determination of proteolytic enzymes using 
various substrates of protein or synthetics'5l 28> 9> 49> ioi川 45J24J15>1•>21>. At present, no method 
can be found in literatures which enable precise determination of trypsin alone, among theEe 
enzymes having resembling physiochemical and enzymological character. On the other hand, 
although it is r田 dilypresumed that trypsin plays the principal role clinically as a proteolytic 
enzymes in acute pancreatitis, it is assumed that, besides trvpsin, pancreatogenic chymotrypsin, 
carboxypeptidase, enzymes of kallil王reingroup and plasmin, as considered to he activated 
secondarily, interfer the enzymodynamics more or le民 bringingforth a complicated picture. 
It was studied by BERGMANN3l as early as in 1939, that synthetic substrate B. A . .¥. (ben-
zoyl-1-arginine amide hydrochloride) is decomposed almost exclusively by trypsin. NARDI・s 
method37l reported in 1958 in which above mentioned characteristics of B. A. A. and 
CoNWAY's8> microdiffusion analvsis method are utilized, might well be considered to be a 
satisfactory method for the determination of trypsin activity, since the influence of other 
coexisting enzymes is so slight as to be neglected compared with trypsin itself, even though 
it四 nnotbe said precisely that there is no interference of other enzymes in this method. 
Of course, there are some disadvantages in this method, the greatest problem is the limit 
of macroscopic reading of the terminal point of titration. Owing to macroscopic reading 
of the point of the change in color at titration, standard deviation is nピcess;1rilyipt to 
expand. 入札、orclingly,NARDI himself reported that 山mdard deviation w部土50units, 
when the maximum normal value was determin日lto hじ 100units. With the rnicrohiurette 
as used in the presゼntexperiment, prec1s1on does not 仁ウ虻
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e. 0.35×10-4 A. U Further development in the precision can be expected in the near 
future, since there are several reports 14> 5> to represent the results photometrically using B. 
A. A. substrate, although it was not executed in the present experiment. 
In general, activity of trypsin inhibitor is represented by the activity of trypsin that 
was inhibited by trypsin inhibitor, and the amount of trypsin inhibited is proportionate to 
that of trvpsin inhibitorm. A.ccordingly, the principle of the determination consists in sub-
stracting residual trypsin activity from the original one after these two are let react to each 
other. There are various methods for the determination of trypsin inhibitor, i. e. antitryptic 
activiれ，2si10J49J13J17J11H5J24i. There is, however, litle difference in the principle of these 
methods using different substrate, buffer system or the judgement of the results of titration. 
It is a matter of course that the method employed here, i. e. GROB’s method回 nnotbe 
any exception and trypsin inhibitor of combined form is not determined. On the contrary, 
resultメ ofKALSER-GROSSMAN、日 method includes trypsin inhibitor of combined form besides 
that of isolated form, as the compound is decomposed during the process of extraction and 
trypsin forming the compound simultaneously precipitates leaving trypsin inhibitor within 
the solvent. Morecl¥・er, it is considered that the determination has better reproducibility 
when hemoglobin is used as substrate than othげ ones1l.
In this method of trypsin inhibitor determination, the material is relatively well diluted, 
the principal aim of which, of course, consists in making the material appropriate concentra-
tion for photometry. However, more important significance therein should consists in 
weakening the activity of other proteolytic enzymes by dilution in order to avoid untoward 
interference of these enzymes by lessening these compared with trypsin added afterwards. 
With the only exception of tissue extract, value of blank determination devoid of trypsin 
was so small as to be neglected. In addition, it is said that there is interfering effect 
against the reaction in low dilution of serum47l. According to the report of J主COBSSON24l,
antitryptic inhibition of町rumis directly proportionate to the amount of serum added up 
to 70 per cent inhibition. In the pr引 t:nt experiment, it was ascertained by examining 
above mentioned dilution that inhibition was below 70 per cent. 
Although some literatures could be、ト込町n,which admit or presume existence of trypsin 
inhibitor in the tissue叫， noliterature could be found concerning the method of the deter-
mination. Of course, it is not clear whether or not trypsin inhibitor within the tissue be 
identical to the substance already known such as trypsin inhibitor in serum. MACFAR-
LANトHJreported the results of determination of plasmin inhibitor in various tissues. Ac-
じordingto the recently acquired knowledge, some of trypsin inhibitors so closely resemble 
plasmin inhibitor in its charactげ thatthe determination of trypsin inhibitor in the tissues 
was carried out based on the method of !¥hcFARL孔NE. It is known that plasmin inhibitor 
widely exists in the tissues of the entire body, and it is presumed that trypsin inhibitor 
also may possibly exist similarly.人じι、ordingly,trypsin inhibitor should have been more widely 
pursued in various tissues at acute pancreatiti,,, but it was hardly possible in such experiment 
as to take tissue specimens川内mall;1mount frequently clurin広thecりurseof acute pancreatitis 
Trypsin inhibitor of the tissue wa内 determinedin the Ii＼℃r and s1】leen in the present 
experiment based on the following r山川Il民i According to M ¥CF.¥T¥L.¥NE, the spleen which 
¥¥'<I弓 t<1kenin the present experiment is the organ that is the richest in plasrnin. Further-
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more, the liver is thought anatomically to be the first organ that po同 ibly meets large 
amount of liberated trypsin at acute pancreatitis, and these two are suited to repeatinε 
biopsy because of their large volume. 
It has been described and observed by many including >Jr「T. ¥ in our clinic that various 
enzymes are liberated continuously to the surrounding tissues and peritoneal cavity and 
hemato-or lymphogenously to circulating blood at acute pancreatitis following destruction 
of the pancreatic tissue due to elevation of inner pressure of the pancreas and or autαli・
gestion of the organ. Among these liberated enzymes, proteolytic ones such as trypsin 
are thought to be inactivated shortly in most part by corresponding inhibitory properties, 
and remarkable increase cannot be observed even by various methods of determination. 
In the present experiment, first of al rapid increase in active trypsin in blood could 
be observed shortly after the production of acute pancreatitis. This finding is interpreted 
that trypsin itself, which is activated, even if a small amount, by some moment, acts as 
an activator of trypsinogen, and the rapid increase in trypsin might be the result of suc-
cessive trypsin activation within the pancreas51>. At this point, P. T. I. firstly acts to 
neutralize the increased trypsin, but as trypsin is once liberated from the pancreas, parti-
cularly into the blood stream, it must be inactivated by trypsin inhibitor most part of 
which may presumably be serum trypsin inhibitor and represented as A. T. A. in blood, 
richly existing there and having a large reserve capacity. Here, active trypsin and A. T. 
A. behaved during the entire course of the observation, as if in an enzymodynamic equi-
librium, as shown in Fig. 2. At 6th hour of the disease, however, temporary decrease 
in A. T. A. could be observed as if replying to rapid increase in active trypsin obser、td
at this stage. It is quite natural that this finding should be accepted to be due to neu-
tralization of rapidly increased trypsin; and, on the other hand, it is also presumed to b~ 
due to transfer of serum trypsin inhibitor into the ti対 U引. Rapid increase following this 
transient decrease might be attributed to the supply of trypsin inhibitor by some mecha-
nism. This interpretation is particularly interesting when considered with the fact that 
early death occurred in a state of decrease in A. T. A., showing no tendency of reじ0＼.ヒrv
in A. T.A. 
On the other side, P. T. I. showed obviously different change from that of t巧’psin
with the maximum value at the 5th day of the disease, which well resembled the results 
of the change in antiproteolytic activity in the pancreatic tissue reported by 0DA56>61> It 
is assumed so long as Fig. 2 is concerned that there is no correlation between the changes 
in P T. I. and other two properities of active trypsin and A. T. A. PECK and DENVER42> 
maintained that most part of trypsin which entered blood stream is inactivated within re-
latively short period, which was also ascertained in the present experiment by injecting 
trypsin intravenously. This finding can be presumed to suggest that the amount of liberated 
trypsin at acute pancreatitis would be unexpectedly large, and on the contrary, that of P 
T. I. participated in this process unexpectedly small. As already mentioned above, slightly 
higher level of active trypsin and markedly lower level of A. T. A. were observed in 
cases of early death compared with those in ca耐 N of lon氏、llr¥")¥";tJ, it I宍 consideredto be 
significant as one of factorメofdevelopment of the cli同a~c that t＜収etherwith the i1cn;1,.c 
in liberated trypsin A. T. A. in blood or rじ礼・n’t、札1pplyof 人． T. 人． 日＞esto dn川 e
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L、oncerningthe mechanism of peritoneal fluid accumulation, two different processes 
can be considered such a~ immediate exudation of fluid containing high concentration of 
enzymes through the pancreatic capsule, as was demonstrated by NITTA in our clinic, and 
exudation of relatively large amount of fluid from widely covering peritoneum. Although 
there is litle difference between active trvpsin in peritoneal fluid and serum, the former 
invariably exceeded the later, which is particularly marked at initial stage within 12 hours 
after the onset of the disease. It is presumably due to the fact that at this stage exudate 
from the peritoneum does not come to sufficiently large amount compared with the amount 
of pancreatic exudate of high concentration. In other words, highly concentrated pancreatic 
exudate is not diluted and neutralized sufficiently at this stage. This interpretation is sup-
ported by the observation that P. T. I. in peritoneal fluid surpassed P T. I.in serum. 
According to the finding of exploratory laparotomy, peritoneal fluid was most accumulated 
around 48th hour of the disease and later than 72th hour it decreased gradually, making 
its collection difficult. It is assumed that such dilution-effect works to maintain P. T. I. of 
peritoneal fluid in a constant level despite an increase in P. T. I. in serum later than 24 
hours after the onset of the disease. On the other hand, A. T. A. in serum and peritoneal 
fluid changed in parallel, the later being constantly in a level of about 75 per cent of 
the former, which is accepted to support the presumption that A. T. A. mostly originated 
from the peritoneal exudate than fron】 pancreaticexudate. 
Since the early experiments of GOODPASTURE and WHIPPLE52J, there have not been 
so many reports on the problem of peritoneal fluid accumulated at acute pancreatitis. There 
is an impression that toxicity of the fluid has been solely emphasized as a common con-
ception. As is understood from the results of the present experiment, however, there stil 
remains some problems to be studied concerning the significance of the peritoneal fluid. 
The peritoneal fluid is consisted of the fluid immediately originated from the pancreas and 
another one. It can be infered that the former, containing highly concentrated enzymes, 
acts more or les to stimulate the peritoneum, and the latter is produced reactively. It was 
clarified by NITTA that pancreatic exudate of small amount manifests a pronounced toxi-
city, which is weakened a great deal by peritoneal exudate produced a litle later, the 
former being neutralized and diluted. For instance, trypsin activity is weakened nearly to 
the level of peripheral blood, and thus weakened fluid remains in the peritoneal cavity for 
certain period of time until absorbed gradually. Accordingly, it is naturally presumed that 
the toxicity of the peritoneal fluid against important organs and tissues is already wealぜned
markedly compared with initial one. 
It has been known that '-Y111ptom日 ofintravenous injection of trypsin resemble so 
closely to those of acutぞ pancreatitisclinically seen, in many respects・ Accordingly,for 
the aim of studying pathophvs川）I-()'of acute pancreatitis, it is meaningful to clarify beha-
vior of trypsin inhibitor at trypsin injection to analogize the occasion of acute pancreatitis・
A宍 PECKand DENVER42J reported, mo'-'t什fI rypsin injected in the present experiment was 
inactivated within anヒxtrernelvshort period. The】ughit l只 am乳terof course that active 
trypsin in l】loodsl 
aftゼr’particularh- until 60 rninut正、只 later,alrno日tentire trypsin injected being inactivated 
120 minutιヘaftげ tl1l'injection. Thi~ finding coinci<k叫 withthe result of ARAKI04J. There 
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remains some problems to consider that such phenomenon is entirely due to trypsin inhi-
bitor, however, in this process it is assumed that trypsin inhibitor has at least significance 
to considerable extent, and a rapid decrease in A. T. A. at this stage also support this 
concept. In many respects there is difference in the response against trypsin injection in 
normal and survived dogs. For example, difference in A. T. A. between the groups of 
normal and survived animals became extremely remarkable later than 60 minutes after the 
injection of trypsin. In normal animals, A. T. A. reached nearly zero 100 minutes after 
the injection, restoring slightly thereafter. This l内 acceptedto suggest that the mechanism 
of A. T. A. supply begins to work as late as this stage. In survived dogs, it is presumed 
that ceriain factor somewhat different from those in normal animals are participating in 
the mechanism of A. T. A. supply, as suggested from gradual increase in A. T. A. and 
rapid decrease in active trypsin 60 minutes after the injection. Although individual dif-
ference was naturally observed more or les in other normal animalメ， thetendency was 
constant as a whole. 
Blood pressure fel swiftly within a few minutes after the injection of trypsin. Survived 
dogs almost recovered 150 minutes after the injection, while normal dogs stil remain in 
a state of shock at this period, without any sign of recovery. 
It is worth while noticing that there was such a remarkable difference between normal 
dogs and survived ones despite the injection of trypsin with the same condition. In sur-
vived dogs, as shown in the present experiment, once markedly fluctuated active trypsin 
and trypsin inhibitor 2 weeks after the onset of the disease had restored to preoperative 
level. As the explanation for this observation, various possibilities can be presumed. Fir叫ly,
inhibitor-precursor may be activated by some moment to become the inhibitor and compensate 
the deficit of it, secondly, trypsin inhibitor or its precursor existing in the tissues may be 
mobilized to blood stream and thirdly, both of these two may participate in the process. 
Since precursor of trypsin inhibitor cannot be determined at present, possible existence of 
trypsin inhibitor in the tissue and its change were investigated in the present experiment. 
Such possibility can be considered necessarily not only at the injection of trypsin but also 
in acute pancreatitis. From al〕ovementioned reasons, observations were carried out in the 
liver and spleen, the results of which are summarized in Fig. 8. Although the changes 
in trypsin inhibitor in the tissues were different between normal and survived dogs, it cannot 
be immediately concluded that trypsin inhibitor in the tissues is mobilized into blood stream, 
from this difference. However, concerning trypsin inhibitor in the tissue in dogs of acute 
pancreatitis, an interesting results of inverted relationship between the inhibitor in serum 
and tissues in the initial stage of the disease, as shown in Fig. 9, which is accepted to sug-
gest the possibility of mobilization of trypsin inhibitor in the tissues into blood stream. 
Particularly, it is considered from the responsive change inえ.T. A. in the liver against 
that in serum at 6th hour that mobilization of trypsin inhibitor occurs more easily from 
the liver under certain conditions. Such phnomenon, how引とr,may be transient, since the 
liver meets particularly large amount of liberated trypsin initially owing to its anatomical 
relation, and it can not be denied to presume that trypsin inhibitor was supplied here con-
trariwise from the blood stream. 
On the other hand, some reports15i2n are seen that activity of trypsin inhibitor merじ山附
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at tissue destructing lesions. Hence, the possibility that trypsin inhibitor in inactivated type 
within the normal tissue may be activated by some factors at destruction of the tissue and 
liberated into the blood stream cannot be ignored. 
:¥!though A. T. A. level at exploratory laparotomy fluctuated more or les, the pat-
tern was definitely different from that of acute pancreatitis. Its change being small, results 
of the present experiment is litle influenced by it. 
To summarize the above, it is as follows. 
Unexpectedly large amount of trypsin is liberated at acute pancre泊titisas well as other 
enzymes, and it is strongly suggested that this liberated trypsin is inactivated first by P. 
T. I. and further by trypsin inhibitor in blood more strongly, which is represented as A. 
T. A., leaving slight activity of trypsin. Concerning the toxicity of trypsin, in recent years, 
toxic substances activated by trypsin is discussed besides trypsin itself, as indirect effect of 
trypsin. 
Pathophysiological significance of trypsin inhibitor is even more great, since it primarily 
inhibits not only trypsin but these secondary substances. It is a matter of course that be-
sides trypsin inhibitor many factors should be considered to influence the prognosis of acute 
pancreatitis. It is assumed, however, that activity of trypsin inhibitor may well represents 
an aspect of degree of defence, and storage or reserve capacity of trypsin inhibitor would 
he a factor determining the outcome of the disease. This is also confirmed by the ob-
servation of RusH and CLIFFTON43> that death also occurred in the animals with entire with-
drawal of antiproteolytic activity by kaolin injection. Trypsin inhibitor is so much labile 
due to various conditions such as individuality and others, and there remain some problems 
for the diagnostic utilization. Concerning the correlation between trypsin and trypsin in-
hibitor, only the approximate outline could be disclosed by the method of determination 
employed in the present experiment, since there is no accurate method of determination 
at present for each property of trypsin inhibitor and trypsin and trypsin inhibitor in com-
pound form. In addition, it is easily presumed that some part of trypsin inhibitor is con-
sumed for the neutralization of other proteolytic enzymes60>, as mentioned in the above, 
which makes the problem even more complicated in investigation of the correlation bet-
ween trypsin and trypsin inhibitor. 
Concerning the significance of peritoneal fluid, as mentioned repeatedly, its effect of 
lessening the toxicity by dilution and neutralization should be noticed. Accordingly, opera-
sion modus of merely traditional removal of peritoneal fluid at acute pancreatitis should 
be further studied. 
RusH and CLIFFTON43> reportヒdan increase in antiproteolytic activity in patients re割
以＞veredfrom acute pancreatitis. In the present experiment also greater antagonistic capa-
city against newly injected trypsin could be demonstrated in survived dogs, giving an in-
teresting impression as if it werεimmune state after recovered from some diseases. In the 
present experiment, immunological study was not carried out, but G1ws19> insisted that the 
reaction hetween trvpsin and antitrypsin should be considered to be different from antigen-
antibody reaction. Any way, this prodlem is particularly interesting in another respect of 
chronic relapsing pancreatitis. 
By examining attitude of trypsin inhibitor in blood and tissues, a possibility of mutual 
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transfer between these two and, further, complexity of defence mechanism of organism 
were strongly suggested. 
V. SUMMARY 
Acute pancreatitis was experimentally produecd in dogs, and active trypsin and trypsin 
inhibitor were determined. The results obtained were summarized as follows ; 
1. From a series of experiments, it was strongly suggested that trypsin is liberated 
at acute pancreatitis hematogenously, lymphogenously and immediately to the surrounding 
tissues, most of which is shortly inactivated by trypsin inhibitor in the pancreas and blood. 
2. Increase in active trypsin and decrease in trypsin inhibitor in blood are more re-
markable in the cases of serious development of the disease compared with those of mild 
one. 
3. Attitude of active trypsin and trypsin inhibitor in peritoneal fluid was somewhat 
different from that of blood and significance of peritoneal fluid as buffer for trypsin should 
be recognized. 
4. Possibility of mutual transfer between trypsin inhibitor in blood and tissues was 
suggested. 
5. Higher resistance against trypsin injection was observed in dogs once survived 
acute pancreatitis than in normal dogs. 
In ぽじomplishingthe pr白entpaper, the author is deeply indebted tけ l’l<I Dr. Irnm HoNJO for his kind gu1-
danc白 andsupervision, the author is at the回metime gratefulぃDr.lTsuo MIYAZAKI and members of our clinic 
for their kind advices札口dhelps. 
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和文抄録
急性豚炎に於けるTrypsinInhibitorの推移
金沢大乍~，＿；： .、戸 ；＇；1;;:j'.\ 2 外科教室（主任本庄一 犬~ Jそ ）
。z 雄
急性豚炎に際し， 1也醇哀の如くに血中 Tryp;;inが上 21 勝炎の中， E徒化を来たすものは軒1IT：で経過
昇しない現象の一因として，生体内 Trypsinlnhihitnr するものに比べ n'Il中治性 Tryp可inの｜：坪花ぴに .n'r.f:t
による不活性化の問題が考えられる．著者はこの可能 Tr河川 Inhihitorの減少が著明である．
性を確かめ，叉 Trypsinlnh耐torと逸脱 Trypsinの 3J 腹腔濠出液中の情性 Trypsin,Trypsin lnhihitor 
相互関係を明らかにするためp 犬の脈管内に自家胆 の消長はJ(l中の夫れとは多rレ異なった態度をとり， 詰S
F卜をi:・入して実験的に；（，＇.d'flf.むを作成した上， J;t/: /l:'，液の Tryp尽in緩術作用に意義を附すべきである．
Trypsin 役び TrypsinInhibit口rを測定し i人’の知見を 1) J(正中 Tryp>inInhibitorと組織中 TrypsinInbi-
得た． l山》rの伺互移行の可能性が考えられる．
I l 諸種の ’有毒~f:.'i 県，豚炎時 Trypsi n も種々の形 5 I Trypsin i'Jt; i'.1こ対し，一度豚炎を経過せる犬は
で厚手より逸脱する，ぅ：，これらの大部分は勝 Inhibitor 正常lとよりも Tn・p,in健軍基に抵抗性の高いのが証明
並びにJill中 Inhibitor によ り 短時間で l'；川｜化 ~ ~ l ろ されt:.
事が強く暗示される．
